The global ophthalmology packaging market is projected to grow from USD 1,816.5 million in 2024 to USD 3,063.9 million by 2034. In the forecast period 2024 to 2034, the industry is set to surge at 5.4% CAGR. The revenue generated by ophthalmology packaging in 2023 was USD 1,734.5 million and is anticipated to exhibit a y-o-y growth of 4.7% in 2024.
Tubes are predominately used in ophthalmology packaging, capturing around 42% of the value share in 2034. Ophthalmology packaging solutions with a capacity of 6 to 10 ml are set to generate an incremental revenue of USD 766.5 million by 2034.
Dynamics of Ophthalmology Packaging
| Attributes | Key Insights |
|---|---|
| Base Value (2023) | USD 1,734.5 million |
| Estimated Industry Size (2024E) | USD 1,816.5 million |
| Projected Industry Valuation (2034F) | USD 3,063.9 million |
| Value-based CAGR (2024 to 2034) | 5.4% |
Growing population, quickening technical developments, and increasing awareness of eye care are the key aspects that are projected to surge growth of the ophthalmology packaging market. A key factor propelling growth is the increasing prevalence of ocular disorders.
Age-related muscle degeneration, red-eye syndrome, conjunctivitis, cataracts, and dry eyes are among the most common eye conditions. These disorders necessitate eye care and several additional therapies, which in turn have a favorable impact on the demand for Ophthalmology packing.
The development of innovative packaging materials and the growing requirement to follow new legal standards on recycling packaging materials contribute to growth. The industry is projected to experience lucrative growth during the forecast period.
Sales are set to rise from 2024 to 2034 and are projected to generate an incremental growth opportunity of USD 6,532 million. The industry is further predicted to inflate 1.6x times the current value during the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global ophthalmology packaging market recorded a CAGR of 4.1% from 2019 to 2023. The industry was valued at USD 1,734.5 million in 2023 from USD 1,478.0 million in 2019.
The advent of novel packaging materials and technologies greatly impacted the ophthalmology packaging market in the historical period. The industry adopted innovations, including blister packaging, unit dose packaging, and tamper-evident sealing, as they have high product safety, convenience, and shelf life.
The need for environmentally friendly packaging solutions in the ophthalmology industry increased due to laws supporting sustainability and rising environmental awareness. Manufacturers started using recyclable, biodegradable, and renewable materials more frequently to lessen their ecological impact and win over environmentally concerned customers.
Patient-centric packaging designs that put ease of use, safety, and compliance first have also gained traction. Easy-to-open seals, concise instructions, and ergonomic designs are a few instances of packaging elements intended to improve patient experience and prescription adherence, especially for older or visually impaired patients.
By 2034, the eye drop packaging market is projected to surge at 5.4% CAGR. Increasing population, lifestyle changes, and aging are causing eye-related infections to rise. Increasing prevalence of eye infections is fueling the demand for ophthalmology products.
The pharmaceutical industry is subjected to strong regulations such as good manufacturing practices for ensuring the packaging on delivery of ophthalmology products. Innovative and new pharmaceutical packaging formats are being developed by manufacturing companies to meet the demand for safe & sterile packaging of ophthalmology products across the world.
Rising Prevalence of Eye Infections
Increasing prevalence of eye infections primarily propels ophthalmology packaging. Growing usage of contact lenses, antibiotic resistance, and certain environmental factors contribute to the surging cases of eye infections globally.
For instance, trachoma is a kind of bacterial infection caused by chlamydia trachomatis. It has created a public health issue in around 42 countries. This infection can lead to visual impairment in 1.9 million people worldwide.
People are increasingly affected by eye infections because of improper eye hygiene practices. Using contaminated eye products and not washing hands before touching the eyes are contributing to growth of increased eye infections, further surging demand.
Increasing prevalence of ophthalmology disorders is leading to escalating demand for eye drops and ointments. Conditions such as dry eye syndrome, glaucoma, allergies, and other eye issues are becoming more common among people, surging the demand for eye care products. Growing prevalence of these infections contributes to growth of ophthalmology packaging market.
Development of Affordable, Accessible, and Effective Generic Ophthalmology Drugs
An increasing number of eye disorders and infections is leading to the development of innovative ophthalmology care solutions for treatments. Pharmaceutical companies are investing in developing innovative, affordable, and effective ophthalmology drugs for the patient's well-being. For instance, researchers are reviewing the strategies for enhancing ocular bioavailability in medication administration.
Several studies show that conventional eye drops often lose their effectiveness due to blinking tear production, resulting in less than 5% bioavailability. Nano particles-based drugs are gaining popularity for enhancing bioavailability and accommodating various pharmaceuticals.
Such formulations offer improved ocular permeability, prolonged residence time, and stabilizing medicines. Innovating these drugs with affordability is set to inflate their application to a wider range of people. These innovations and developments are further projected to lead to growth.
Principal Consultant
The table presents the projected CAGR for the industry over several semi-annual periods from 2023 to 2034. In the first half (H1) of the decade from 2023 to 2033, the industry is set to surge at a CAGR of 5.9%, followed by a slightly lower growth rate of 4.7% in the second half (H2) of the same decade.
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to increase slightly to 5.0% in the first half and surge to 6.3% in the second half. These values offer insights into the anticipated growth trends for the industry, aiding stakeholders and investors in making decisions regarding investments & strategies.
| Particular | Value CAGR |
|---|---|
| H1 | 5.9% (2023 to 2033) |
| H2 | 4.7% (2023 to 2033) |
| H1 | 5.0% (2024 to 2034) |
| H2 | 6.3% (2024 to 2034) |
The categorical ophthalmology packaging market analysis is mentioned in the section below. Based on inclusive investigations, the tube sector is controlling the packaging type category. Furthermore, the eye drop segment is set to propel the application category upwards.
| Packaging Type | Value CAGR (2024 to 2034) |
|---|---|
| Tubes | 5.4% |
| Bottles | 4.7% |
Tubes are widely used in packaging because of their durability, versatility, and suitability for different ophthalmology products. This packaging offers transparency, lightweight, barrier, and cost-efficient properties beneficial for ophthalmology products.
Tubes are designed to preserve the sterility of eye medications and protect from external contaminations. The inertness and convenience of tubes are leading to their widespread adoption in the market. Tube segment is anticipated to reach USD 1,296.9 million and is projected to grow 5.4% CAGR by 2034.
| Applications | Value CAGR (2024 to 2034) |
|---|---|
| Eye Drops | 5.0% |
| Ophthalmology Ointment | 6.2% |
Eye drops are the leading application in the industry and are projected to gain a market revenue worth USD 636.2 million by 2034. Eye drops are highly contributing to the growth of the ophthalmology packaging market, propelled by the increased application of eye care products.
Conditions such as dry eye, conjunctivitis, cataracts, and other age-related problems have led to the surging demand for eye drops. The aging population in the world and the occurrence of ocular diseases are further boosting the usage of eye drops. Eye drops are vital in creating relief for eye conditions, and their ease of use is increasing their application in the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below examines the state of the ophthalmology packaging industry in some of the leading countries on the global stage, such as the United States, Japan, Canada, China, and India. Through in-depth research, the report has evaluated the aspects influencing these nations' acceptability and growth of novel packaging solutions.
In North America, Canada is projected to remain dominant by showcasing a CAGR of 6.2%, while the United States is estimated to remain at 4.7% through 2034. In South Asia & Pacific, India is set to exhibit a CAGR of 8.3% in the same timeframe.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| United States | 4.7% |
| Canada | 6.2% |
| Brazil | 4.9% |
| Mexico | 5.3% |
| Germany | 3.8% |
| France | 4.4% |
| United Kingdom | 4.0% |
| China | 6.2% |
| India | 8.3% |
| Japan | 3.7% |
| KSA | 6.5% |
| South Africa | 6.4% |
Increasing prevalence of eye infections due to the growing adoption of contact lenses is projected to push people toward ophthalmology eye drops and ointments in the United States. The country is set to reach a valuation of USD 710.1 million, soaring at a CAGR of 4.7% by 2034.
Age-related macular degeneration, glaucoma, and dry eye syndrome are among the many eye-related illnesses that affect a considerable portion of the United States population. The need for ophthalmology medications is pushed by the aging population and rising incidence of chronic eye illnesses, impacting the ophthalmology packaging industry.
Aged people are more prone to eye diseases, which is an effective key factor for Japan’s ophthalmology packaging market. According to the World Economic Forum, almost 1/3rd of Japan's population is over 65 years old, accounting for 36.23 million people contributing to the older population.
It is a key factor in influencing the demand for ophthalmology packaging as older people get most eye problems due to the weakening of their eyesight. Japan is anticipated to surge at 3.7% CAGR through 2034.
Japan’s ophthalmology packaging market is further shaped by developments in packaging materials and technologies, including unit dosage packaging, preservative-free packaging, and sophisticated drug delivery systems. Enhancing patient comfort, product safety, and compliance are the key goals of these improvements in the ophthalmology packaging market.
China is predicted to experience rapid growth at a CAGR of 6.2% through 2034 due to rising demand for fast and reliable ophthalmology packaging solutions. The industry is propelled by the need for security, patient comfort, tamper-evident technology, and high-quality products. Growing social security and healthcare systems trend in China presents new growth opportunities for ophthalmology packaging providers in the industry.
Canada dominates the ophthalmology packaging market, surging at a CAGR of 6.2% through 2034. Rising ocular disorders, export of ophthalmology products, investments in research & development, and stringent regulatory policies are projected to surge the demand for ophthalmology packaging in Canada.
Canada is also a key consumer of plastics due to their versatility, easy molding, and resistance to water & climate. Furthermore, the aging population, favorable government policies, and increased healthcare expenditure are estimated to surge the industry in the country.
Manufacturers are directed toward developing and launching new products to broaden their reach. Leading companies are integrating with different firms and surging their geographical presence.
They are also collaborating and partnering with brands & companies for product development. Recent activities and developments implemented by leading players are:
The industry consists of five types of packaging solutions, namely, tubes, bottles, syringes, flexible pouches, and ampoules & vials. Both laminated and extruded plastic tubes are mainly demanded by customers. Bottles made of plastic and glass, on the other hand, are gaining impetus.
Packaging solutions in the capacity of less than 2 ml, 2 to 5 ml, 6 to 10 ml, and above 10 ml are showcasing immense popularity globally.
There are several distribution channels in the industry, including institutional sales, retail sales, and e-commerce. Institutional sales channel consists of hospitals, ophthalmology clinics, public health agencies, and veterinary hospitals & clinics. Drug stores and retail pharmacies/supermarkets are estimated to create high popularity in terms of retail sales channels.
Over-the-counter (OTC) and prescription are the two main types of orders.
Several applications, such as eye drops, ophthalmology gels, ophthalmology ointment, and anti-VEGF drugs, are covered.
Some of the significant cases include refractive errors, cataracts & glaucoma, retinal disorders, corneal diseases, pediatric ophthalmology, neuro-ophthalmology, ophthalmology plastic surgery, uveitis & ocular inflammation, and other eye care cases.
Information about leading countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe, and the Middle East & Africa is provided.
The industry is set to reach USD 1,816.5 million in 2024.
The industry was worth USD 1,734.5 million in 2023.
Demand for ophthalmology packaging is set to surge at a 5.4% CAGR by 2034.
The market is set to reach USD 3,063.9 million in 2034.
Amcor Plc, Berry Global, and Schott AG.
Tube segment is estimated to hold a significant share in 2024.
Rising prevalence of eye infections and growing investments in affordable drugs.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Market Background 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Packaging Type 8.1. Tubes 8.1.1. Laminated Tubes 8.1.2. Extruded Plastic Tubes 8.2. Bottles 8.2.1. Glass Bottle 8.2.2. Plastic Bottle 8.3. Syringes 8.4. Flexible Pouches 8.5. Ampoules & Vials 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Capacity 9.1. Less than 2ml 9.2. 2 to 5 ml 9.3. 6 to 10 ml 9.4. Above 10 ml 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel 10.1. Institutional Sales 10.1.1. Hospitals 10.1.2. Ophthalmology Clinics 10.1.3. Public Health Agencies 10.1.4. Veterinary Hospitals & Clinics 10.2. Retail Sales 10.2.1. Retail Pharmacies / Supermarkets 10.2.2. Drug Stores 10.3. E-Commerce 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Applications 11.1. Eye Drops 11.2. Ophthalmology Gels 11.3. Ophthalmology Ointment 11.4. Anti-VEGF Drugs 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Order Type 12.1. OTC (Over-the-Counter) 12.2. Prescription 13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End Use Cases 13.1. Refractive Errors 13.2. Cataracts & Glaucoma 13.3. Retinal Disorders 13.4. Corneal Diseases 13.5. Pediatric Ophthalmology 13.6. Neuro-Ophthalmology 13.7. Ophthalmology Plastic Surgery 13.8. Uveitis and Ocular Inflammation 13.9. Other Eye Care End-use Cases 14. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 14.1. North America 14.2. Latin America 14.3. Western Europe 14.4. South Asia 14.5. East Asia 14.6. Eastern Europe 14.7. Middle East & Africa 15. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. South Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 19. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 20. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 21. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 22. Sales Forecast 2024 to 2034 by Packaging Type, Capacity, Distribution Channel, Applications, Order Type, and End Use Cases for 30 Countries 23. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 24. Company Profile 24.1. Amcor plc 24.2. Tekni-Plex Inc 24.3. Recipharm AB 24.4. Gerresheimer AG 24.5. SCHOTT AG 24.6. Berry Global Inc 24.7. West Pharmaceutical Services, Inc. 24.8. Aptar group 24.9. ALPLA Group 24.10. Hoffmann Neopac 24.11. Nemera Development S.A. 24.12. Röchling SE & Co. KG 24.13. Taisei Kako Co.,Ltd. 24.14. Shionogi Pharma Co., Ltd. 24.15. Nichi-Iko Pharmaceutical Co., Ltd 24.16. Shenzhen Bona Pharma Technology Co. 24.17. Shijiazhuang Xinfuda Medical Packaging Co. 24.18. Zhengzhou Nuohua Plastic Products Co.,Ltd. 24.19. Origin Pharma Packaging 24.20. DEMCO PTY LTD
Explore Packaging Insights
View Reports
Ophthalmology Packaging Market
